Global Vaccines Market 2025-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	194 Pages	TechNavio	January, 2025	INF19520112

Best Price Guarantee
Price	from $2,500
Length	194 Pages
Publisher	TechNavio
Published Date	January, 2025
SKU	INF19520112

Vaccines Market 2025-2029

The vaccines market is forecasted to grow by USD 193.7 bn during 2024-2029, accelerating at a CAGR of 23% during the forecast period. The report on the vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increased funding for vaccine development and new vaccine launches, need for novel vaccines for chronic infections, and increasing use of adjuvants in vaccines.

Technavio's vaccines market is segmented as below:

By Type

Human vaccine
Animal vaccine

By End-user

Hospitals
Clinics

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the development of nanoparticle vaccines as one of the prime reasons driving the vaccines market growth during the next few years. Also, increase in awareness of vaccine-preventable diseases among travelers and advancement in vaccine delivery system will lead to sizable demand in the market.

The report on the vaccines market covers the following areas:

Vaccines Market sizing
Vaccines Market forecast
Vaccines Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vaccines market vendors that include Astellas Pharma Inc., AstraZeneca Plc, Bavarian Nordic AS, Bharat Biotech Ltd., BrightPath Biotherapeutics Co., Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., Emergent BioSolutions Inc., GSK Plc, Gradalis Inc., Inovio Pharmaceuticals Inc., Johnson and Johnson Inc., Merck KGaA, Mitsubishi Chemical Group Corp., Novavax Inc., Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Valneva SE. Also, the vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary: 1.1 Market overview; Executive Summary - Chart on Market Overview; Executive Summary - Data Table on Market Overview; Executive Summary - Chart on Global Market Characteristics; Executive Summary - Chart on Market By Geographical Landscape; Executive Summary - Chart on Market Segmentation by Type; Executive Summary - Chart on Market Segmentation by End-user; Executive Summary - Chart on Incremental Growth; Executive Summary - Data Table on Incremental Growth; Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis: 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; 2.2 Criticality of inputs and Factors of differentiation; Overview on criticality of inputs and factors of differentiation; 2.3 Factors of disruption; Overview on factors of disruption; 2.4 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029
3 Market Landscape: 3.1 Market ecosystem; Parent Market; Data Table on - Parent Market; 3.2 Market characteristics; Market characteristics analysis; 3.3 Value chain analysis; Value chain analysis
4 Market Sizing: 4.1 Market definition; Offerings of companies included in the market definition; 4.2 Market segment analysis; Market segments; 4.3 Market size 2024; 4.4 Market outlook: Forecast for 2024-2029; Chart on Global - Market size and forecast 2024-2029 ($ billion); Data Table on Global - Market size and forecast 2024-2029 ($ billion); Chart on Global Market: Year-over-year growth 2024-2029 (%); Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size: 5.1 Global Vaccines Market 2019 - 2023; Historic Market Size - Data Table on Global Vaccines Market 2019 - 2023 ($ billion); 5.2 Type segment analysis 2019 - 2023; Historic Market Size - Type Segment 2019 - 2023 ($ billion); 5.3 End-user segment analysis 2019 - 2023; Historic Market Size - End-user Segment 2019 - 2023 ($ billion); 5.4 Geography segment analysis 2019 - 2023; Historic Market Size - Geography Segment 2019 - 2023 ($ billion); 5.5 Country segment analysis 2019 - 2023; Historic Market Size - Country Segment 2019 - 2023 ($ billion)
6 Qualitative Analysis: 6.1 Impact of AI on the Global Vaccines Market
7 Five Forces Analysis: 7.1 Five forces summary; Five forces analysis - Comparison between 2024 and 2029; 7.2 Bargaining power of buyers; Bargaining power of buyers - Impact of key factors 2024 and 2029; 7.3 Bargaining power of suppliers; Bargaining power of suppliers - Impact of key factors in 2024 and 2029; 7.4 Threat of new entrants; Threat of new entrants - Impact of key factors in 2024 and 2029; 7.5 Threat of substitutes; Threat of substitutes - Impact of key factors in 2024 and 2029; 7.6 Threat of rivalry; Threat of rivalry - Impact of key factors in 2024 and 2029; 7.7 Market condition; Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Type: 8.1 Market segments; Chart on Type - Market share 2024-2029 (%); Data Table on Type - Market share 2024-2029 (%); 8.2 Comparison by Type; Chart on Comparison by Type; Data Table on Comparison by Type; 8.3 Human vaccine - Market size and forecast 2024-2029; Chart on Human vaccine - Market size and forecast 2024-2029 ($ billion); Data Table on Human vaccine - Market size and forecast 2024-2029 ($ billion); Chart on Human vaccine - Year-over-year growth 2024-2029 (%); Data Table on Human vaccine - Year-over-year growth 2024-2029 (%); 8.4 Animal vaccine - Market size and forecast 2024-2029; Chart on Animal vaccine - Market size and forecast 2024-2029 ($ billion); Data Table on Animal vaccine - Market size and forecast 2024-2029 ($ billion); Chart on Animal vaccine - Year-over-year growth 2024-2029 (%); Data Table on Animal vaccine - Year-over-year growth 2024-2029 (%); 8.5 Market opportunity by Type; Market opportunity by Type ($ billion); Data Table on Market opportunity by Type ($ billion)
9 Market Segmentation by End-user: 9.1 Market segments; Chart on End-user - Market share 2024-2029 (%); Data Table on End-user - Market share 2024-2029 (%); 9.2 Comparison by End-user; Chart on Comparison by End-user; Data Table on Comparison by End-user; 9.3 Hospitals - Market size and forecast 2024-2029; Chart on Hospitals - Market size and forecast 2024-2029 ($ billion); Data Table on Hospitals - Market size and forecast 2024-2029 ($ billion); Chart on Hospitals - Year-over-year growth 2024-2029 (%); Data Table on Hospitals - Year-over-year growth 2024-2029 (%); 9.4 Clinics - Market size and forecast 2024-2029; Chart on Clinics - Market size and forecast 2024-2029 ($ billion); Data Table on Clinics - Market size and forecast 2024-2029 ($ billion); Chart on Clinics - Year-over-year growth 2024-2029 (%); Data Table on Clinics - Year-over-year growth 2024-2029 (%); 9.5 Market opportunity by End-user; Market opportunity by End-user ($ billion); Data Table on Market opportunity by End-user ($ billion)
10 Customer Landscape: 10.1 Customer landscape overview; Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape: 11.1 Geographic segmentation; Chart on Market share By Geographical Landscape 2024-2029 (%); Data Table on Market share By Geographical Landscape 2024-2029 (%); 11.2 Geographic comparison; Chart on Geographic comparison; Data Table on Geographic comparison; 11.3 North America - Market size and forecast 2024-2029; Chart on North America - Market size and forecast 2024-2029 ($ billion); Data Table on North America - Market size and forecast 2024-2029 ($ billion); Chart on North America - Year-over-year growth 2024-2029 (%); Data Table on North America - Year-over-year growth 2024-2029 (%); 11.4 Europe - Market size and forecast 2024-2029; Chart on Europe - Market size and forecast 2024-2029 ($ billion); Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Chart on Europe - Year-over-year growth 2024-2029 (%); Data Table on Europe - Year-over-year growth 2024-2029 (%); 11.5 Asia - Market size and forecast 2024-2029; Chart on Asia - Market size and forecast 2024-2029 ($ billion); Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Chart on Asia - Year-over-year growth 2024-2029 (%); Data Table on Asia - Year-over-year growth 2024-2029 (%); 11.6 Rest of World (ROW) - Market size and forecast 2024-2029; Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); 11.7 US - Market size and forecast 2024-2029; Chart on US - Market size and forecast 2024-2029 ($ billion); Data Table on US - Market size and forecast 2024-2029 ($ billion); Chart on US - Year-over-year growth 2024-2029 (%); Data Table on US - Year-over-year growth 2024-2029 (%); 11.8 UK - Market size and forecast 2024-2029; Chart on UK - Market size and forecast 2024-2029 ($ billion); Data Table on UK - Market size and forecast 2024-2029 ($ billion); Chart on UK - Year-over-year growth 2024-2029 (%); Data Table on UK - Year-over-year growth 2024-2029 (%); 11.9 Germany - Market size and forecast 2024-2029; Chart on Germany - Market size and forecast 2024-2029 ($ billion); Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Chart on Germany - Year-over-year growth 2024-2029 (%); Data Table on Germany - Year-over-year growth 2024-2029 (%); 11.10 Canada - Market size and forecast 2024-2029; Chart on Canada - Market size and forecast 2024-2029 ($ billion); Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Chart on Canada - Year-over-year growth 2024-2029 (%); Data Table on Canada - Year-over-year growth 2024-2029 (%); 11.11 China - Market size and forecast 2024-2029; Chart on China - Market size and forecast 2024-2029 ($ billion); Data Table on China - Market size and forecast 2024-2029 ($ billion); Chart on China - Year-over-year growth 2024-2029 (%); Data Table on China - Year-over-year growth 2024-2029 (%); 11.12 India - Market size and forecast 2024-2029; Chart on India - Market size and forecast 2024-2029 ($ billion); Data Table on India - Market size and forecast 2024-2029 ($ billion); Chart on India - Year-over-year growth 2024-2029 (%); Data Table on India - Year-over-year growth 2024-2029 (%); 11.13 France - Market size and forecast 2024-2029; Chart on France - Market size and forecast 2024-2029 ($ billion); Data Table on France - Market size and forecast 2024-2029 ($ billion); Chart on France - Year-over-year growth 2024-2029 (%); Data Table on France - Year-over-year growth 2024-2029 (%); 11.14 Japan - Market size and forecast 2024-2029; Chart on Japan - Market size and forecast 2024-2029 ($ billion); Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Chart on Japan - Year-over-year growth 2024-2029 (%); Data Table on Japan - Year-over-year growth 2024-2029 (%); 11.15 Brazil - Market size and forecast 2024-2029; Chart on Brazil - Market size and forecast 2024-2029 ($ billion); Data Table on Brazil - Market size and forecast 2024-2029 ($ billion); Chart on Brazil - Year-over-year growth 2024-2029 (%); Data Table on Brazil - Year-over-year growth 2024-2029 (%); 11.16 Russia - Market size and forecast 2024-2029; Chart on Russia - Market size and forecast 2024-2029 ($ billion); Data Table on Russia - Market size and forecast 2024-2029 ($ billion); Chart on Russia - Year-over-year growth 2024-2029 (%); Data Table on Russia - Year-over-year growth 2024-2029 (%); 11.17 Market opportunity By Geographical Landscape; Market opportunity By Geographical Landscape ($ billion); Data Tables on Market opportunity By Geographical Landscape ($ billion)
12 Drivers, Challenges, and Opportunity/Restraints: 12.1 Market drivers; 12.2 Market challenges; 12.3 Impact of drivers and challenges; Impact of drivers and challenges in 2024 and 2029; 12.4 Market opportunities/restraints
13 Competitive Landscape: 13.1 Overview; 13.2 Competitive Landscape; Overview on criticality of inputs and factors of differentiation; 13.3 Landscape disruption; Overview on factors of disruption; 13.4 Industry risks; Impact of key risks on business
14 Competitive Analysis: 14.1 Companies profiled; Companies covered; 14.2 Company ranking index; Company ranking index; 14.3 Market positioning of companies; Matrix on companies position and classification; 14.4 Astellas Pharma Inc.; Astellas Pharma Inc. - Overview; Astellas Pharma Inc. - Product / Service; Astellas Pharma Inc. - Key offerings; SWOT; 14.5 AstraZeneca Plc; AstraZeneca Plc - Overview; AstraZeneca Plc - Product / Service; AstraZeneca Plc - Key news; AstraZeneca Plc - Key offerings; SWOT; 14.6 Bavarian Nordic AS; Bavarian Nordic AS - Overview; Bavarian Nordic AS - Product / Service; Bavarian Nordic AS - Key offerings; SWOT; 14.7 Bharat Biotech Ltd.; Bharat Biotech Ltd. - Overview; Bharat Biotech Ltd. - Product / Service; Bharat Biotech Ltd. - Key offerings; SWOT; 14.8 BrightPath Biotherapeutics Co., Ltd.; BrightPath Biotherapeutics Co., Ltd. - Overview; BrightPath Biotherapeutics Co., Ltd. - Product / Service; BrightPath Biotherapeutics Co., Ltd. - Key offerings; SWOT; 14.9 CSL Ltd.; CSL Ltd. - Overview; CSL Ltd. - Business segments; CSL Ltd. - Key news; CSL Ltd. - Key offerings; CSL Ltd. - Segment focus; SWOT; 14.10 Daiichi Sankyo Co. Ltd.; Daiichi Sankyo Co. Ltd. - Overview; Daiichi Sankyo Co. Ltd. - Product / Service; Daiichi Sankyo Co. Ltd. - Key news; Daiichi Sankyo Co. Ltd. - Key offerings; SWOT; 14.11 Emergent BioSolutions Inc.; Emergent BioSolutions Inc. - Overview; Emergent BioSolutions Inc. - Product / Service; Emergent BioSolutions Inc. - Key offerings; SWOT; 14.12 GSK Plc; GSK Plc - Overview; GSK Plc - Business segments; GSK Plc - Key news; GSK Plc - Key offerings; GSK Plc - Segment focus; SWOT; 14.13 Gradalis Inc.; Gradalis Inc. - Overview; Gradalis Inc. - Product / Service; Gradalis Inc. - Key offerings; SWOT; 14.14 Johnson and Johnson Inc.; Johnson and Johnson Inc. - Overview; Johnson and Johnson Inc. - Business segments; Johnson and Johnson Inc. - Key news; Johnson and Johnson Inc. - Key offerings; Johnson and Johnson Inc. - Segment focus; SWOT; 14.15 Merck KGaA; Merck KGaA - Overview; Merck KGaA - Business segments; Merck KGaA - Key news; Merck KGaA - Key offerings; Merck KGaA - Segment focus; SWOT; 14.16 Novavax Inc.; Novavax Inc. - Overview; Novavax Inc. - Product / Service; Novavax Inc. - Key offerings; SWOT; 14.17 Pfizer Inc.; Pfizer Inc. - Overview; Pfizer Inc. - Product / Service; Pfizer Inc. - Key news; Pfizer Inc. - Key offerings; SWOT; 14.18 Sanofi SA; Sanofi SA - Overview; Sanofi SA - Business segments; Sanofi SA - Key news; Sanofi SA - Key offerings; Sanofi SA - Segment focus; SWOT
15 Appendix: 15.1 Scope of the report; 15.2 Inclusions and exclusions checklist; Inclusions checklist; Exclusions checklist; 15.3 Currency conversion rates for US$; Currency conversion rates for US$; 15.4 Research methodology; Research methodology; 15.5 Data procurement; Information sources; 15.6 Data validation; Data validation; 15.7 Validation techniques employed for market sizing; Validation techniques employed for market sizing; 15.8 Data synthesis; Data synthesis; 15.9 360 degree market analysis; 360 degree market analysis; 15.10 List of abbreviations; List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Global Market Characteristics; Exhibits4: Executive Summary - Chart on Market By Geographical Landscape; Exhibits5: Executive Summary - Chart on Market Segmentation by Type; Exhibits6: Executive Summary - Chart on Market Segmentation by End-user; Exhibits7: Executive Summary - Chart on Incremental Growth; Exhibits8: Executive Summary - Data Table on Incremental Growth; Exhibits9: Executive Summary - Chart on Company Market Positioning; Exhibits10: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits11: Overview on criticality of inputs and factors of differentiation; Exhibits12: Overview on factors of disruption; Exhibits13: Impact of drivers and challenges in 2024 and 2029; Exhibits14: Parent Market; Exhibits15: Data Table on - Parent Market; Exhibits16: Market characteristics analysis; Exhibits17: Value chain analysis; Exhibits18: Offerings of companies included in the market definition; Exhibits19: Market segments; Exhibits20: Chart on Global - Market size and forecast 2024-2029 ($ billion); Exhibits21: Data Table on Global - Market size and forecast 2024-2029 ($ billion); Exhibits22: Chart on Global Market: Year-over-year growth 2024-2029 (%); Exhibits23: Data Table on Global Market: Year-over-year growth 2024-2029 (%); Exhibits24: Historic Market Size - Data Table on Global Vaccines Market 2019 - 2023 ($ billion); Exhibits25: Historic Market Size - Type Segment 2019 - 2023 ($ billion); Exhibits26: Historic Market Size - End-user Segment 2019 - 2023 ($ billion); Exhibits27: Historic Market Size - Geography Segment 2019 - 2023 ($ billion); Exhibits28: Historic Market Size - Country Segment 2019 - 2023 ($ billion); Exhibits29: Five forces analysis - Comparison between 2024 and 2029; Exhibits30: Bargaining power of buyers - Impact of key factors 2024 and 2029; Exhibits31: Bargaining power of suppliers - Impact of key factors in 2024 and 2029; Exhibits32: Threat of new entrants - Impact of key factors in 2024 and 2029; Exhibits33: Threat of substitutes - Impact of key factors in 2024 and 2029; Exhibits34: Threat of rivalry - Impact of key factors in 2024 and 2029; Exhibits35: Chart on Market condition - Five forces 2024 and 2029; Exhibits36: Chart on Type - Market share 2024-2029 (%); Exhibits37: Data Table on Type - Market share 2024-2029 (%); Exhibits38: Chart on Comparison by Type; Exhibits39: Data Table on Comparison by Type; Exhibits40: Chart on Human vaccine - Market size and forecast 2024-2029 ($ billion); Exhibits41: Data Table on Human vaccine - Market size and forecast 2024-2029 ($ billion); Exhibits42: Chart on Human vaccine - Year-over-year growth 2024-2029 (%); Exhibits43: Data Table on Human vaccine - Year-over-year growth 2024-2029 (%); Exhibits44: Chart on Animal vaccine - Market size and forecast 2024-2029 ($ billion); Exhibits45: Data Table on Animal vaccine - Market size and forecast 2024-2029 ($ billion); Exhibits46: Chart on Animal vaccine - Year-over-year growth 2024-2029 (%); Exhibits47: Data Table on Animal vaccine - Year-over-year growth 2024-2029 (%); Exhibits48: Market opportunity by Type ($ billion); Exhibits49: Data Table on Market opportunity by Type ($ billion); Exhibits50: Chart on End-user - Market share 2024-2029 (%); Exhibits51: Data Table on End-user - Market share 2024-2029 (%); Exhibits52: Chart on Comparison by End-user; Exhibits53: Data Table on Comparison by End-user; Exhibits54: Chart on Hospitals - Market size and forecast 2024-2029 ($ billion); Exhibits55: Data Table on Hospitals - Market size and forecast 2024-2029 ($ billion); Exhibits56: Chart on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits57: Data Table on Hospitals - Year-over-year growth 2024-2029 (%); Exhibits58: Chart on Clinics - Market size and forecast 2024-2029 ($ billion); Exhibits59: Data Table on Clinics - Market size and forecast 2024-2029 ($ billion); Exhibits60: Chart on Clinics - Year-over-year growth 2024-2029 (%); Exhibits61: Data Table on Clinics - Year-over-year growth 2024-2029 (%); Exhibits62: Market opportunity by End-user ($ billion); Exhibits63: Data Table on Market opportunity by End-user ($ billion); Exhibits64: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits65: Chart on Market share By Geographical Landscape 2024-2029 (%); Exhibits66: Data Table on Market share By Geographical Landscape 2024-2029 (%); Exhibits67: Chart on Geographic comparison; Exhibits68: Data Table on Geographic comparison; Exhibits69: Chart on North America - Market size and forecast 2024-2029 ($ billion); Exhibits70: Data Table on North America - Market size and forecast 2024-2029 ($ billion); Exhibits71: Chart on North America - Year-over-year growth 2024-2029 (%); Exhibits72: Data Table on North America - Year-over-year growth 2024-2029 (%); Exhibits73: Chart on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits74: Data Table on Europe - Market size and forecast 2024-2029 ($ billion); Exhibits75: Chart on Europe - Year-over-year growth 2024-2029 (%); Exhibits76: Data Table on Europe - Year-over-year growth 2024-2029 (%); Exhibits77: Chart on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits78: Data Table on Asia - Market size and forecast 2024-2029 ($ billion); Exhibits79: Chart on Asia - Year-over-year growth 2024-2029 (%); Exhibits80: Data Table on Asia - Year-over-year growth 2024-2029 (%); Exhibits81: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits82: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion); Exhibits83: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits84: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%); Exhibits85: Chart on US - Market size and forecast 2024-2029 ($ billion); Exhibits86: Data Table on US - Market size and forecast 2024-2029 ($ billion); Exhibits87: Chart on US - Year-over-year growth 2024-2029 (%); Exhibits88: Data Table on US - Year-over-year growth 2024-2029 (%); Exhibits89: Chart on UK - Market size and forecast 2024-2029 ($ billion); Exhibits90: Data Table on UK - Market size and forecast 2024-2029 ($ billion); Exhibits91: Chart on UK - Year-over-year growth 2024-2029 (%); Exhibits92: Data Table on UK - Year-over-year growth 2024-2029 (%); Exhibits93: Chart on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits94: Data Table on Germany - Market size and forecast 2024-2029 ($ billion); Exhibits95: Chart on Germany - Year-over-year growth 2024-2029 (%); Exhibits96: Data Table on Germany - Year-over-year growth 2024-2029 (%); Exhibits97: Chart on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits98: Data Table on Canada - Market size and forecast 2024-2029 ($ billion); Exhibits99: Chart on Canada - Year-over-year growth 2024-2029 (%); Exhibits100: Data Table on Canada - Year-over-year growth 2024-2029 (%); Exhibits101: Chart on China - Market size and forecast 2024-2029 ($ billion); Exhibits102: Data Table on China - Market size and forecast 2024-2029 ($ billion); Exhibits103: Chart on China - Year-over-year growth 2024-2029 (%); Exhibits104: Data Table on China - Year-over-year growth 2024-2029 (%); Exhibits105: Chart on India - Market size and forecast 2024-2029 ($ billion); Exhibits106: Data Table on India - Market size and forecast 2024-2029 ($ billion); Exhibits107: Chart on India - Year-over-year growth 2024-2029 (%); Exhibits108: Data Table on India - Year-over-year growth 2024-2029 (%); Exhibits109: Chart on France - Market size and forecast 2024-2029 ($ billion); Exhibits110: Data Table on France - Market size and forecast 2024-2029 ($ billion); Exhibits111: Chart on France - Year-over-year growth 2024-2029 (%); Exhibits112: Data Table on France - Year-over-year growth 2024-2029 (%); Exhibits113: Chart on Japan - Market size and forecast 2024-2029 ($ billion); Exhibits114: Data Table on Japan - Market size and forecast 2024-2029 ($ billion); Exhibits115: Chart on Japan - Year-over-year growth 2024-2029 (%); Exhibits116: Data Table on Japan - Year-over-year growth 2024-2029 (%); Exhibits117: Chart on Brazil - Market size and forecast 2024-2029 ($ billion); Exhibits118: Data Table on Brazil - Market size and forecast 2024-2029 ($ billion); Exhibits119: Chart on Brazil - Year-over-year growth 2024-2029 (%); Exhibits120: Data Table on Brazil - Year-over-year growth 2024-2029 (%); Exhibits121: Chart on Russia - Market size and forecast 2024-2029 ($ billion); Exhibits122: Data Table on Russia - Market size and forecast 2024-2029 ($ billion); Exhibits123: Chart on Russia - Year-over-year growth 2024-2029 (%); Exhibits124: Data Table on Russia - Year-over-year growth 2024-2029 (%); Exhibits125: Market opportunity By Geographical Landscape ($ billion); Exhibits126: Data Tables on Market opportunity By Geographical Landscape ($ billion); Exhibits127: Impact of drivers and challenges in 2024 and 2029; Exhibits128: Overview on criticality of inputs and factors of differentiation; Exhibits129: Overview on factors of disruption; Exhibits130: Impact of key risks on business; Exhibits131: Companies covered; Exhibits132: Company ranking index; Exhibits133: Matrix on companies position and classification; Exhibits134: Astellas Pharma Inc. - Overview; Exhibits135: Astellas Pharma Inc. - Product / Service; Exhibits136: Astellas Pharma Inc. - Key offerings; Exhibits137: SWOT; Exhibits138: AstraZeneca Plc - Overview; Exhibits139: AstraZeneca Plc - Product / Service; Exhibits140: AstraZeneca Plc - Key news; Exhibits141: AstraZeneca Plc - Key offerings; Exhibits142: SWOT; Exhibits143: Bavarian Nordic AS - Overview; Exhibits144: Bavarian Nordic AS - Product / Service; Exhibits145: Bavarian Nordic AS - Key offerings; Exhibits146: SWOT; Exhibits147: Bharat Biotech Ltd. - Overview; Exhibits148: Bharat Biotech Ltd. - Product / Service; Exhibits149: Bharat Biotech Ltd. - Key offerings; Exhibits150: SWOT; Exhibits151: BrightPath Biotherapeutics Co., Ltd. - Overview; Exhibits152: BrightPath Biotherapeutics Co., Ltd. - Product / Service; Exhibits153: BrightPath Biotherapeutics Co., Ltd. - Key offerings; Exhibits154: SWOT; Exhibits155: CSL Ltd. - Overview; Exhibits156: CSL Ltd. - Business segments; Exhibits157: CSL Ltd. - Key news; Exhibits158: CSL Ltd. - Key offerings; Exhibits159: CSL Ltd. - Segment focus; Exhibits160: SWOT; Exhibits161: Daiichi Sankyo Co. Ltd. - Overview; Exhibits162: Daiichi Sankyo Co. Ltd. - Product / Service; Exhibits163: Daiichi Sankyo Co. Ltd. - Key news; Exhibits164: Daiichi Sankyo Co. Ltd. - Key offerings; Exhibits165: SWOT; Exhibits166: Emergent BioSolutions Inc. - Overview; Exhibits167: Emergent BioSolutions Inc. - Product / Service; Exhibits168: Emergent BioSolutions Inc. - Key offerings; Exhibits169: SWOT; Exhibits170: GSK Plc - Overview; Exhibits171: GSK Plc - Business segments; Exhibits172: GSK Plc - Key news; Exhibits173: GSK Plc - Key offerings; Exhibits174: GSK Plc - Segment focus; Exhibits175: SWOT; Exhibits176: Gradalis Inc. - Overview; Exhibits177: Gradalis Inc. - Product / Service; Exhibits178: Gradalis Inc. - Key offerings; Exhibits179: SWOT; Exhibits180: Johnson and Johnson Inc. - Overview; Exhibits181: Johnson and Johnson Inc. - Business segments; Exhibits182: Johnson and Johnson Inc. - Key news; Exhibits183: Johnson and Johnson Inc. - Key offerings; Exhibits184: Johnson and Johnson Inc. - Segment focus; Exhibits185: SWOT; Exhibits186: Merck KGaA - Overview; Exhibits187: Merck KGaA - Business segments; Exhibits188: Merck KGaA - Key news; Exhibits189: Merck KGaA - Key offerings; Exhibits190: Merck KGaA - Segment focus; Exhibits191: SWOT; Exhibits192: Novavax Inc. - Overview; Exhibits193: Novavax Inc. - Product / Service; Exhibits194: Novavax Inc. - Key offerings; Exhibits195: SWOT; Exhibits196: Pfizer Inc. - Overview; Exhibits197: Pfizer Inc. - Product / Service; Exhibits198: Pfizer Inc. - Key news; Exhibits199: Pfizer Inc. - Key offerings; Exhibits200: SWOT; Exhibits201: Sanofi SA - Overview; Exhibits202: Sanofi SA - Business segments; Exhibits203: Sanofi SA - Key news; Exhibits204: Sanofi SA - Key offerings; Exhibits205: Sanofi SA - Segment focus; Exhibits206: SWOT; Exhibits207: Inclusions checklist; Exhibits208: Exclusions checklist; Exhibits209: Currency conversion rates for US$; Exhibits210: Research methodology; Exhibits211: Information sources; Exhibits212: Data validation; Exhibits213: Validation techniques employed for market sizing; Exhibits214: Data synthesis; Exhibits215: 360 degree market analysis; Exhibits216: List of abbreviations